Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Helsinn Healthcare SA
Helsinn Healthcare SA
Centre Hospitalier Universitaire de Nice
Eli Lilly and Company
Breast Cancer Trials, Australia and New Zealand
Marmara University
The Hospital for Sick Children
Heron Therapeutics
Shandong Cancer Hospital and Institute
University of Health Sciences Lahore
Bilecik Seyh Edebali Universitesi
Fenerbahce University
Hospices Civils de Lyon
Universitas Muhammadiyah Surakarta
Centre Francois Baclesse
University Medical Center Groningen
Denver Health and Hospital Authority
M.D. Anderson Cancer Center
Sichuan Cancer Hospital and Research Institute
Chongqing University Cancer Hospital
The Hospital for Sick Children
Baskent University
Ankara University
Hacettepe University
Västernorrland County Council, Sweden
Saglik Bilimleri Universitesi
Selcuk University
International University of Health and Welfare
Shanghai Children's Medical Center
University of Health Sciences Lahore
Second Affiliated Hospital, School of Medicine, Zhejiang University
Arbeitsgemeinschaft medikamentoese Tumortherapie
Affiliated Hospital of Qinghai University
University Hospital Freiburg
Rennes University Hospital
Alliance for Clinical Trials in Oncology
Çankırı Karatekin University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Ege University
UNC Lineberger Comprehensive Cancer Center
Rush University Medical Center
Australasian Leukaemia and Lymphoma Group
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Helsinn Healthcare SA
Kyowa Kirin Co., Ltd.
Indonesia University
University of Central Florida
St.Gallen University of Applied Sciences
Lanzhou University Second Hospital
Canadian Cancer Trials Group